Nuvation Bio Inc. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (2 lists). Names and jurisdictions are as filed.
- 2026-03-02: Subsidiary AnBio Therapeutics (HK) Ltd.; Jurisdiction Hong Kong.
- 2026-03-02: Subsidiary AnHeart Therapeutics LLC; Jurisdiction Delaware.
- 2026-03-02: Subsidiary Nuvation Bio China Ltd.; Jurisdiction China.
- 2026-03-02: Subsidiary Artemis Merger Sub II; Jurisdiction Cayman Islands.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-02 | AnBio Therapeutics (HK) Ltd. | Hong Kong |
| 2026-03-02 | AnHeart Therapeutics LLC | Delaware |
| 2026-03-02 | Nuvation Bio China Ltd. | China |
| 2026-03-02 | Artemis Merger Sub II | Cayman Islands |
| 2026-03-02 | Baoquan Biomedical Technology (Shanghai) Co. Ltd. | China |
| 2026-03-02 | Nuvation Bio Operating Company LLC | Delaware |
| 2026-03-02 | Nuvation Bio Ireland Limited | Ireland |
| 2026-03-02 | Nuvation Bio UK Limited | United Kingdom |
| 2026-03-02 | RePharmation Ltd. | Bermuda |
| 2025-03-06 | AnBio Therapeutics (HK) Ltd. | Hong Kong |
| 2025-03-06 | AnHeart Therapeutics LLC | Delaware |
| 2025-03-06 | AnHeart Therapeutics (Hangzhou) Co., Ltd. | China |
| 2025-03-06 | Artemis Merger Sub II | Cayman Islands |
| 2025-03-06 | Baoquan Biomedical Technology (Shanghai) Co. Ltd. | China |
| 2025-03-06 | Nuvation Bio Operating Company LLC | Delaware |
| 2025-03-06 | Nuvation Bio Ireland Limited | Ireland |
| 2025-03-06 | Nuvation Bio UK Limited | United Kingdom |
| 2025-03-06 | RePharmation Ltd. | Bermuda |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |